The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP.
about
Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic reviewPhenotyping bleedingContemporary management of primary immune thrombocytopenia in adultsSevere hemorrhage in children with newly diagnosed immune thrombocytopenic purpuraIntracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases.Consensus Paper-ICIS Expert Meeting Basel 2009 treatment milestones in immune thrombocytopeniaPlatelet microparticles in immune thrombocytopenic purpura in pediatrics.Differences in platelet function in patients with acute myeloid leukemia and myelodysplasia compared to equally thrombocytopenic patients with immune thrombocytopenia.Risk and prognosis of adult primary immune thrombocytopenia.Platelet count or bleeding as the outcome in ITP trials?Bleeding severity as an important outcome in childhood immune thrombocytopenia.Combination of recombinant factor VIIa and fibrinogen corrects clot formation in primary immune thrombocytopenia at very low platelet counts.Telomerase activity increased and telomere length shortened in peripheral blood cells from patients with immune thrombocytopenia.Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy.High response rate to low-dose rituximab plus high-dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia.Low-dose anti-CD20 veltuzumab given intravenously or subcutaneously is active in relapsed immune thrombocytopenia: a phase I study.Contemporary treatment of immune thrombocytopenia.Health-related quality of life in adult patients with chronic immune thrombocytopenia in Serbia.Beyond the platelet count: immature platelet fraction and thromboelastometry correlate with bleeding in patients with immune thrombocytopenia.Management of thrombocytopenia.A novel canine model of immune thrombocytopenia: has immune thrombocytopenia (ITP) gone to the dogs?Systematic analysis of bleeding phenotype in PT-VWD compared to type 2B VWD using an electronic bleeding questionnaire.Evaluation of the immature platelet fraction in the diagnosis and prognosis of childhood immune thrombocytopenia.Immunosuppressive treatment combined with nucleoside analog is superior to nucleoside analog only in the treatment of severe thrombocytopenia in patients with cirrhosis associated with hepatitis B in China: A multicenter, observational study.Investigation of platelet function and platelet disorders using flow cytometry.Treatment of refractory ITP and Evans syndrome by haematopoietic cell transplantation: is it indicated, and for whom?Effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patients with immune thrombocytopenia.Prediction of bleeding and prophylactic platelet transfusions in cancer patients with thrombocytopenia.Real-life management of primary immune thrombocytopenia (ITP) in adult patients and adherence to practice guidelines.Fibrinogen concentrate improves clot strength in patients with haematological malignancies requiring platelet transfusion.Platelet Apoptosis in Adult Immune Thrombocytopenia: Insights into the Mechanism of Damage Triggered by Auto-AntibodiesComparison of two dosing schedules for subcutaneous injections of low-dose anti-CD20 veltuzumab in relapsed immune thrombocytopenia.Increasing observation rates in low-risk pediatric immune thrombocytopenia using a standardized clinical assessment and management plan (SCAMP® ).Evaluation of platelet function in thrombocytopenia.The effect of rituximab on anti-platelet autoantibody levels in patients with immune thrombocytopenia.The role of tandem stem cell transplantation for multiple myeloma patients.Endothelial alterations in a canine model of immune thrombocytopenia.Fostamatinib for the Treatment of Adult Persistent and Chronic Immune Thrombocytopenia: Results of Two Phase 3, Randomized, Placebo-Controlled Trials.Development and implementation of a novel immune thrombocytopenia bleeding score for dogs.Efficacy and Safety of a New 10% Intravenous Immunoglobulin Product in Patients with Primary Immune Thrombocytopenia (ITP).
P2860
Q26826853-83FFEB46-1E9B-4BC4-9F1B-25BA25C483B0Q26830732-B87982E7-D22D-4135-AE8E-2D310E9F37EDQ26853680-FE297747-ECC5-4748-B534-70B92962B2C2Q33380732-4350012D-A53A-4FD7-B5B0-F5D0B42D0C75Q33386303-59814594-AB2C-4286-99AF-46CED6E75616Q33389001-832A4004-7305-4E4F-A6E0-8595FEFD9542Q33389339-DE7C6234-0F05-497F-99C5-A329C9DF81C7Q33397223-6DB58DA8-A46A-409F-BC13-B60AF9171AF7Q33400566-58607D26-0DE8-4C21-956A-893E81226758Q33402594-AB413932-5F81-4BCD-A486-DBD2F4C10E89Q33404101-7BA3B216-DD2E-44CD-A44E-72AF0261AC3EQ33404353-9D5AEB69-CE97-4779-B7DE-05B5F66E265EQ33404834-24350817-3437-4F6C-90E5-D5DAB81658F4Q33406032-87FD1430-3AA6-4D60-9F85-DA71DFBF2044Q33406310-3583AE58-2B33-41E0-9C0A-639DB96ACFABQ33408915-06E9383C-98B4-46A1-946B-0619710BC783Q33410653-5BA6291C-661A-4A31-AE6F-F9A3FD87C171Q33411220-C1670BF6-63E6-410E-8044-141AA2930763Q33415059-3DB78381-A21D-4B08-84C2-EBA9AD6651A0Q33416258-63648A64-2203-470E-BEED-80FCD0940092Q33416544-3F52ACAD-543B-4F44-AC56-DFB077C96456Q33416741-94875858-6214-4932-BE19-89160BBF658AQ33418429-C9F24D27-9EF9-4B53-85E6-287ECA530992Q33418708-3D913C73-C0A3-473F-AA10-B8644572C421Q33422250-A39912A5-BFD5-4EEB-B6C0-D91E0CAC6590Q33424451-796AE627-59DF-47E8-8FEF-F3D56698DB96Q33426166-C5FDE985-9F0B-4EC6-8570-A630513E6AF1Q33431119-CFA1C370-54F0-4FB2-9579-41E36B8E1AA3Q33431635-32EC124C-AC03-49BA-8595-F792DF11D2D5Q33432591-647EF1FC-4B7E-459A-9261-EFBCFCA521F5Q33434374-BF647E1D-9965-49A9-9021-A76BBBAC24D2Q33434522-2FB35219-276A-4EA6-942E-1B269ADB9EFDQ33436298-71DEAD84-8A36-4998-88EA-F8BC90CBF954Q33440997-599D0818-C40C-495D-89FA-F6DC33B0E6CCQ33441391-38311C5F-85F2-4183-A1BA-4DA236249E76Q38677358-6FF43370-7945-4E05-B49C-444B9ADA8FB9Q44877409-AD6BD007-67DE-4410-8DF3-0BF44D3E67DDQ52562217-68808982-2BA5-4E1C-BE29-523F1C414AFEQ52571913-91EC2784-E08A-489A-AB97-523177780B9EQ55221178-B2DBDA29-747D-4D10-9CA0-8BC1A4D89C47
P2860
The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The immune thrombocytopenic pu ...... bleeding in patients with ITP.
@ast
The immune thrombocytopenic pu ...... bleeding in patients with ITP.
@en
type
label
The immune thrombocytopenic pu ...... bleeding in patients with ITP.
@ast
The immune thrombocytopenic pu ...... bleeding in patients with ITP.
@en
prefLabel
The immune thrombocytopenic pu ...... bleeding in patients with ITP.
@ast
The immune thrombocytopenic pu ...... bleeding in patients with ITP.
@en
P2093
P1476
The immune thrombocytopenic pu ...... bleeding in patients with ITP.
@en
P2093
Andrew S Elish
Drew Provan
J Michael Hamilton
Julian M Jenkins
Lemke K Page
Martin L Lesser
P304
P356
10.1111/J.1365-2141.2007.06635.X
P407
P577
2007-06-03T00:00:00Z